Clinical features of Parkinson disease when onset of diabetes came first A case-control study

Neurology

Volumn 78, Issue 19, 2012, Pages 1507-1511

  Cereda, E ^a   Barichella, M ^b   Cassani, E ^b   Caccialanza, R ^a   Pezzoli, G ^b  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b PARKINSON INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIPARKINSON AGENT; BIGUANIDE DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LEVODOPA; SULFONYLUREA DERIVATIVE;

ARTICLE; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; INSULIN TREATMENT; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MOTOR ACTIVITY; PARKINSON DISEASE; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE;

EID: 84863625218     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182553cc9     Document Type: Article

References (24)

1. Craft S, Watson GS. Insulin and neurodegenerative disease: shared and specific mechanisms. Lancet Neurol 2004;3:169-178
2. Cardoso S, Correia S, Santos RX, et al. Insulin is a two-edged knife on the brain. J Alzheimer Dis 2009;18:483-507
3. Lu FP, Lin KP, Kuo HK. Diabetes and the risk of multisystem aging phenotypes: a systematic review and metaanalysis. PLoS One 2009;4:e4144
4. Cereda E, Barichella M, Pedrolli C, Pezzoli G. Diabetes and risk of Parkinson's disease: a systematic review and meta-analysis. Diabetes Care 2011;34:2614-2623
5. Hu G, Jousilahti P, Bidel S, Antikainen R, Tuomilehto J. Type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2007;30:842-827
6. Driver JA, Smith A, Buring JE, Gaziano JM, Kurth T, Logroscino G. Prospective cohort study of type 2 diabetes and the risk of Parkinson's disease. Diabetes Care 2008;31:2003-2005
7. Xu Q, Park Y, Huang X, Hollenbeck A, Blair A, Schatzkin A, Chen H. Diabetes and risk of Parkinson's disease. Diabetes Care 2011;34:910-915
8. Sandyk R, Awerbuch GI. The association of diabetes mellitus with dementia in Parkinson's disease. Int J Neurosci 1992;64:209-212
9. Arvanitakis Z, Wilson RS, Schneider JA, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and progression of rigidity and gait disturbance in older persons. Neurology 2004;63:996-1001
10. Arvanitakis Z, Wilson RS, Bienias JL, Bennett DA. Diabetes and parkinsonian signs in older persons. Alzheimer Dis Assoc Disord 2007;21:144-149
11. Kalra S, Grosset DG, Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord 2010;25:149-156
12. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improves the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology 2001; 57(suppl 3):S34-S38
13. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25: 2649-2653
14. Barichella M, Cereda E, Pezzoli G. Major nutritional issues in the management of Parkinson's disease. Mov Disord 2009;24:1881-1892
15. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98-102
16. Haratz S, Tanne D. Diabetes, hyperglycemia and the management of cerebrovascular disease. Curr Opin Neurol 2011;24:81-88
17. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003;112:1821-1830
18. Chen H, O'Reilly EJ, Schwarzschild MA, Ascherio A. Peripheral inflammatory biomarkers and risk of Parkinson's disease. Am J Epidemiol 2008;167:90-95
19. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol 1985; 122:904-914
20. Qiu C, Hu G, Kivipelto M, et al. Association of blood pressure and hypertension with the risk of Parkinson disease: the National FINRISK Study. Hypertension 2011; 57:1094-1100
21. Simon KC, Chen H, Schwarzschild M, Ascherio A. Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease. Neurology 2007;69:1688-1695
22. Hu G, Antikainen R, Jousilahti P, Kivipelto M, Tuomilehto J. Total cholesterol and the risk of Parkinson disease. Neurology 2008;70:1972-1979
23. Chen H, Mosley TH, Alonso A, Huang X. Plasma urate and Parkinson's disease in the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 2009;169: 1064-1069
24. Weisskopf MG, O'Reilly E, Chen H, Schwarzschild MA, Ascherio A. Plasma urate and risk of Parkinson's disease. Am J Epidemiol 2007;166:561-567.